Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.

David P Strachan ORCID logo; Charlotte E Rutter ORCID logo; Monica InnesAsher; KarenBissell; Chen-YuanChiang; AsmaEl Sony; EamonEllwood; PhilippaEllwood; LuisGarcía-Marcos; Guy BMarks; +7 more... EvaMorales; KevinMortimer; Neil Pearce ORCID logo; VirginiaPérez-Fernández; StevenRobertson; Richard JSilverwood; Global Asthma Network Phase I Study Group; Global Asthma Network Phase I Study Group; (2021) Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 33 (1). e13656-. ISSN 0905-6157 DOI: 10.1111/pai.13656
Copy

BACKGROUND: The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ('rhinoconjunctivitis'), which is reported here. METHODS: Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phase I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per capita national income. RESULTS: Twenty-seven GAN centres in 14 countries surveyed 74,361 13- to 14-year-olds ('adolescents') and 45,434 6- to 7-year-olds ('children'), with average response proportions of 90% and 79%, respectively. Many centres showed highly significant (p < .001) changes in prevalence of rhinoconjunctivitis in the past year ('current rhinoconjunctivitis') compared with ISAAC. The direction and magnitude of centre-level trends varied significantly (p < .001) both within and between countries. Overall, current rhinoconjunctivitis prevalence decreased slightly from ISAAC Phase III to GAN: -1.32% per 10 years, 95% CI [-2.93%, +0.30%] among adolescents; and -0.44% [-1.29%, +0.42%] among children. Together, these differed significantly (p < .001) from the upward trend within ISAAC. Among adolescents, centre-level trends in current rhinoconjunctivitis were highly correlated with those for eczema symptoms (rho = 0.72, p < .0001) but not with centre-level trends in asthma symptoms (rho = 0.15, p = .48). Among children, these correlations were positive but not significant. CONCLUSION: Symptoms of non-infective rhinoconjunctivitis among schoolchildren may no longer be on the increase globally, although trends vary substantially within and between countries.


visibility_off picture_as_pdf

picture_as_pdf
pai.13656.pdf
subject
Published Version
lock
Restricted to Repository staff only
Available under Creative Commons: NC-ND 3.0

Request Copy

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: